Founded in 2021, D-Nome operates in the health technology sector and provides a SaaS product for diagnostic data management and analysis. Initially focused on streamlining diagnostic workflows for med...
Funding stage:
Seed
Last funding:
20/01/2023
Total funding:
$1.50 Mn+
Revenue:
Investors
Employee count:
13
Last 90d
13
Last 90d
Web traffic:
781
781
Last 30d
Last 30d
Glassdoor Rating:
D-Nome: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders16
Latest Filing Date18 Jan 2023- Funding Events6
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of D-Nome
As of 19 January 2023, D-Nome's equity is held by 15 shareholders, with the top three being Divya Sriram, Sujoy Deb, and Ankur Capital Fund II.
Divya Sriram holds the largest stake in D-Nome at 28.0% as of 19 January 2023.
As of 19 January 2023, founders collectively hold 55.9% equity in D-Nome.
As of 19 January 2023, investors collectively hold 32.2% equity in D-Nome.
D-Nome's ESOP pool stands at 11.8% of total equity as of 19 January 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links